Skip to main content
Kiambu Medically Assisted Therapy(MAT) clinic 15

MSF hands over opioid-subsitution therapy project in Kenya to local organisations

War in Gaza:: find out how we're responding
Learn more

After five years, Médecins Sans Frontières (MSF) handed over our Medically Assisted Therapy (MAT) treatment facilities for people who use drugs in Kiambu, Kenya to the Department of Health and Kenya Prison Services at the end of June.

This milestone handover of the clinics is made possible due to the training of healthcare workers, and the County Department of Health Services' and Kenya Prisons Services' commitment to provide the services to people who use drugs.

“We have healthcare workers who now have the knowledge on patient care and management of the clinic,” says Dr Elius Maina, County Executive Committee Member, Department of Health Services. “We acknowledge that the MAT services are still crucial for the patients from Kiambu, and for that reason, we will continue with the services even after MSF's exit.”

The MAT clinics are one stop medical facilities approach, with a holistic approach to treatment beyond opioid substitution. Dr Edi Atte, MSF Country Director in Kenya

Kiambu ranks amongst the top counties in Kenya with the highest number of people who use drugs, specifically heroin use. However, before 2019, there was no existing medical facility providing care for people, with few accessing services in Nairobi, over one hour away from most patients.

Since September 2019, 1,619 people have benefited from this holistic programme, with 556 currently receiving care in the clinics. The MAT services are offered within the precincts of Karuri Level 4 hospital in Banana area to reduce opioid addiction, related health risks and deaths, and improve the lives of people who use drugs.

Two other clinics run in partnership with Kenya Prisons Services, in Ruiru Prisons Staff Training College health centre and Thika GK Prison, now serving both incarcerated patients and patients from the local communities. The services were run in partnership with the County Government of Kiambu, Kenya Prisons Services, the National AIDS and STI's Control Programme and LVCT Health.

The three clinics provide methadone and Buprenorphine, in liquid and tablet forms, respectively, as opioid substitution therapy, a component of harm reduction.

“The harm reduction approach aims at reducing negative health, social, legal and financial consequences of drug addiction,” explains Dr Edi Atte, MSF Country Director in Kenya.

Kiambu Medically Assisted Therapy(MAT) clinic 17
Mburu Michael is flanked by his father and uncle as they arrive at the Karuri medically assisted therapy clinic in Karuri for his take home methadone dose. Kenya, May 2024.
Eugene Osidiana/MSF

“The MAT clinics are one stop medical facilities approach, with a holistic approach to treatment beyond opioid substitution. This includes the prevention of infections and transmission of HIV and viral hepatitis which are caused by using unsterile needles, prevention and treatment of TB, mental health and psychosocial support, and re-integration support with family and community,” he explains.

Patient-centered approaches and innovations, such as take-home doses, prison deliveries to incarcerated patients, decentralisation of care and satellite dispensing sites, increase access to MAT services, and recovery chances of people who use drugs. Access to care and proximity to healthcare facilities remain key enablers for health-seeking for this key group of people.

MSF has made significant contributions by establishing clinics closer to patients’ homes to enhance adherence to treatment, including in the prisons and satellite dispensing sites in basic healthcare facilities near them. Patients unable to access the daily methadone dose due to various reasons like illness, injuries or school, get daily home or hospital deliveries through peer educators.

To enhance social reintegration and economic self-reliance, for patients already stable and in school or working, with good support in their recovery journey, and who are unable to make it daily to the facilities, they receive at most two weeks of dosage, that is packaged and locked in a safe box for safe keeping at home.

Beyond medical care, social reintegration and support for patients remains a critical factor in enhancing recovery, and reducing stigma as social and economic support reduces the chances of relapsing. Community support and acceptance, including among healthcare workers, play an important role in the recovery journey and adherence to treatment for people who use drugs.

Up Next
Myanmar
Project Update 12 July 2024